Literature DB >> 26797195

Baseline assessment of a hospital-specific early warning trigger system for reducing maternal morbidity.

Herman L Hedriana1, Suzanne Wiesner2, Brenda G Downs3, Barbara Pelletreau2, Laurence E Shields4.   

Abstract

OBJECTIVE: To determine whether predefined maternal early warning triggers (MEWTs) can predict pregnancy morbidity.
METHODS: In a retrospective case-control study, obstetric patients admitted to the intensive care unit (ICU) between 2012 and 2013 at seven pilot US hospitals were compared with control patients who had a normal delivery outcome. Six MEWTs were assessed.
RESULTS: The case and control groups each contained 50 patients. Hemorrhage (15/50, 30%), sepsis (12/50, 24%), cardiac dysfunction (8/50, 16%), and pre-eclampsia (6/50, 12%) were the most common reasons for ICU admission. Significant associations were recorded between ICU admission and tachycardia (OR 5.0, 95% CI 2.1-11.7), mean arterial pressure less than 65 mm Hg (OR 4.5, 95% CI 1.9-10.8), temperature of at least 38°C (OR 44.1, 95% CI 13.0-839.1), and altered mental state (OR 44.1, 95% CI 13.1-839.0). Two or more triggers were persistent for 30 minutes or more in 36 (72%) ICU patients versus 2 (4%) controls (OR 61.7, 95% CI 13.2-288.0). Earlier medical intervention might have led to a lesser degree of maternal morbidity for 31 (62%) ICU patients with at least one MEWT.
CONCLUSION: Persistent MEWTs were present in most obstetric ICU cases. Retrospectively, MEWTs in this cohort seemed to separate normal obstetric patients from those for whom ICU admission was indicated; their use might reduce maternal morbidity.
Copyright © 2015 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Early warning triggers; ICU admissions; Maternal morbidity

Mesh:

Year:  2015        PMID: 26797195     DOI: 10.1016/j.ijgo.2015.07.036

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  7 in total

1.  Prevalence and management of severe intrapartum hypertension in patients with preeclampsia at an urban tertiary care medical center.

Authors:  Ngozi Nwabueze; Nikolina Docheva; Gabriel Arenas; Ariel Mueller; Joana Lopes Perdigao; Sarosh Rana
Journal:  Pregnancy Hypertens       Date:  2021-12-25       Impact factor: 2.899

2.  Implementing Obstetric Early Warning Systems.

Authors:  Alexander M Friedman; Mary L Campbell; Carolyn R Kline; Suzanne Wiesner; Mary E D'Alton; Laurence E Shields
Journal:  AJP Rep       Date:  2018-04-20

3.  Early warning systems in obstetrics: A systematic literature review.

Authors:  Aminu Umar; Charles A Ameh; Francis Muriithi; Matthews Mathai
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

4.  Effect of a novel vital sign device on maternal mortality and morbidity in low-resource settings: a pragmatic, stepped-wedge, cluster-randomised controlled trial.

Authors:  Nicola Vousden; Elodie Lawley; Hannah L Nathan; Paul T Seed; Muchabayiwa Francis Gidiri; Shivaprasad Goudar; Jane Sandall; Lucy C Chappell; Andrew H Shennan
Journal:  Lancet Glob Health       Date:  2019-03       Impact factor: 26.763

5.  Comparison of early warning scores for predicting clinical deterioration and infection in obstetric patients.

Authors:  David E Arnolds; Kyle A Carey; Lena Braginsky; Roxane Holt; Dana P Edelson; Barbara M Scavone; Matthew Churpek
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-06       Impact factor: 3.007

6.  Application of electronic trigger tools to identify targets for improving diagnostic safety.

Authors:  Daniel R Murphy; Ashley Nd Meyer; Dean F Sittig; Derek W Meeks; Eric J Thomas; Hardeep Singh
Journal:  BMJ Qual Saf       Date:  2018-10-05       Impact factor: 7.035

7.  Development and validation of an obstetric early warning system model for use in low resource settings.

Authors:  Aminu Umar; Alexander Manu; Matthews Mathai; Charles Ameh
Journal:  BMC Pregnancy Childbirth       Date:  2020-09-11       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.